{
    "clinical_study": {
        "@rank": "110972", 
        "arm_group": [
            {
                "arm_group_label": "Diabetes"
            }, 
            {
                "arm_group_label": "Normal glucose regulation"
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole blood,fasting serum and stool"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "primary outcome: To explore the genetic susceptibility of diabetes in Chinese adolescent and\n      youth.\n\n      secondary outcomes:\n\n        1. To classify diabetes by gene detection in Chinese adolescent and youth.\n\n        2. To make the relationship between genotype and clinic phenotype in type 1 diabetes.\n\n        3. To evaluate the effect of environmental factors (intestinal ecosystem)in the\n           pathogenesis of diabetes."
        }, 
        "brief_title": "Genetics of Type 1 Diabetes in Chinese Adolescents and Youth", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "detailed_description": {
            "textblock": "Phase 1: Baseline investigation Aims: To explore genetic susceptibility of diabetes in\n      Chinese adolescent and youth.\n\n      Subjects and Methods: 500 patients under diabetic conditions and sex,age-matched NGR Healthy\n      control(2:1) will be enrolled ,all aged from 14-30 years old. A comprehensive examination\n      including questionnaire, anthropometric measurements, biochemical analysis will be performed\n      in each study participant. Diabetes should be diagnosed according to the WHO 1999\n      criteria,type 1 or type 2 diabetes diagnosed by clinical features recommended by\n      International Society of Pediatric and Adolescent Diabetes ( ISPAD ).\n\n      Phase 2: Cohort follow-up Aims : To explore the association of genetic backgrounds and\n      clinical characteristics in different types of diabetes in Chinese adolescent and youth.\n\n      Subjects and Methods: To recruit and follow up 200 newly diagnosed and genotyped patients\n      for 3 years. Questionnaire, anthropometric measurements, biochemical analysis performed\n      respectively at baseline,3,6,12,24,36 months after enrollment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age: 14- 30 years old\n\n          2. Gender: males and females\n\n          3. Race: han\n\n          4. Diabetes diagnosed by WHO cafeteria (WHO1999)\n\n          5. Living in east China area to minimize population stratification\n\n        Exclusion Criteria:\n\n          1. Secondary diabetes caused by other diseases or drugs\n\n          2. Moderate to severe liver, kidney dysfunction, i.e. ALT/AST > 2.5 times the upper\n             limit of normal range or Ccr < 25ml/min;\n\n          3. Any other condition or major systemic diseases that the investigator feels would\n             interfere with trial participation or evaluation of results."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "14 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "In phase 1:500 patients under diabetic conditions and sex,age-matched NGR(Normal glucose\n        regulation) (2:1) will be enrolled ,all aged from 14-30.\n\n        In phase 2:200 patients newly diagnosed diabetes (less than 6 month before enrollment\n        )will be genotyped and followed up for 3 years"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01938365", 
            "org_study_id": "CCEMD020"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 11, 2013", 
        "location": {
            "contact": {
                "email": "feifei1116@hotmail.com", 
                "last_name": "Guang Ning, Professor", 
                "phone": "8621-64370045", 
                "phone_ext": "665344"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200025"
                }, 
                "name": "Ruijin hospital, Shanghai Jiao-Tong University School of Medicine"
            }, 
            "investigator": {
                "last_name": "Guang Ning, Professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Prospective Cohort Study of Clinical Characteristics and Genetic Susceptibility of Type 1 Diabetes in Chinese Adolescents and Youth", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Deterioration of pancreatic islet function", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01938365"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai Jiao Tong University School of Medicine", 
            "investigator_full_name": "Guang Ning", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Insulin dosage, HbA1c levels and evaluation of chronic complications", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "source": "Shanghai Jiao Tong University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Jiao Tong University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}